justETF App The best app for your ETF search! Download now

FibroGen

ISIN US31572Q8087

WKN A12EZ0

Overview

Description

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.

Show more Show less

Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR	105.19 m
EPS, EUR	-2.71
P/B ratio	-
P/E ratio	-
Dividend yield	0.00%

Income statement (2023)

Revenue, EUR	136.67 m
Net income, EUR	-262.91 m
Profit margin	-192.37%

What ETF is FibroGen in?

There are 2 ETFs which contain FibroGen. All of these ETFs are listed in the table below. The ETF with the largest weighting of FibroGen is the CSIF (IE) MSCI USA Small Cap ESG Leaders Blue UCITS ETF B USD.

ETF	Weight	Investment focus	Holdings	TER	Fund size (in m EUR)	Return 1Y	WKN	ISIN
CSIF (IE) MSCI USA Small Cap ESG Leaders Blue UCITS ETF B USD	0.04%	Equity United States Small Cap	723	0.20%	436	+18.78%	A2P4U1	IE00BMDX0L03
SPDR Russell 2000 US Small Cap UCITS ETF	0.01%	Equity United States Small Cap	1,788	0.30%	2,573	+20.81%	A1XFN1	IE00BJ38QD84

Savings plan offers

Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.

Select your savings amount:

Broker	Rating	Savings plan offer	Account fee	More information
		free of charge	free of charge	More info
		EUR 1.50 1.50%	free of charge	More info